Adient plc
NYSE:ADNTAuto - Parts
+$0.21 today
- Market cap
- $1.15B
- Beta
- 1.51
- P/E (TTM)
- 27.8
- EPS (TTM)
- $0.74
Volume 1.72M
Average 0.97M
ADNT Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Adient plcNYSE: ADNT
Capital Expenditures · Q2 FY2026 · quarter ended Mar 2026
Capital expenditures growth accelerates
Q2 FY2026 capital expenditures of $73M (cash outflow) rose 62.2% year over year, ahead of the +9.2% change in trailing-twelve-month capital expenditures. Sequentially, it rose 12.3% from the prior quarter. Over 3 fiscal years it compounded at +2.6% a year.
Context
- Capital expenditures amounted to 1.7% of revenue in FY2025, down 0.1 pp from a year earlier.
- Capital expenditures grew in size in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +62.2% holds above the trailing-twelve-month pace of +9.2%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (245M) USD
- Year-over-year change
- +7.9%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-09-30 | (245M) | +7.9% |
| FY2024 | 2024-09-30 | (266M) | -5.6% |
| FY2023 | 2023-09-30 | (252M) | -11.0% |
| FY2022 | 2022-09-30 | (227M) | +12.7% |
| FY2021 | 2021-09-30 | (260M) | — |
Capital Expenditures vs competitors
How ADNT compares with its peers on the latest reported figures
- ADNT's LTM Mar 2026 capital expenditures of $274M is the 5th largest of the 14 companies compared; the peer median is $97.49M.
- Its year-over-year change of +9.2% is the 7th highest of 14, against a peer median of -5.2%.
- Capital expenditures amounts to 1.8% of revenue for ADNT, versus a peer median of 2.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $3.17B | +36576.8% | -2.6% | 467.0% | |
| LTM Oct 2026 | $663M | +18.6% | -4.2% | 2.8% | |
| LTM Jun 2026 | $404M | -19.5% | -9.0% | 3.6% | |
| LTM Jun 2026 | $314M | +9.8% | -21.4% | — | |
| LTM Mar 2026 | $274M | +9.2% | +2.6% | 1.8% | |
| LTM Sep 2026 | $223M | +87.4% | +1.6% | 4.9% | |
| LTM Jun 2026 | $128M | -5.2% | +18.0% | 3.4% | |
| LTM Jun 2026 | $97.49M | -34.5% | -4.1% | 3.7% | |
| LTM Mar 2026 | $36.33M | -15.6% | +14.3% | 2.0% | |
| LTM Apr 2026 | $32.18M | -21.4% | -8.1% | 2.2% | |
| LTM Mar 2026 | $16.62M | -32.4% | -11.6% | 2.1% | |
| LTM Mar 2026 | $9.51M | -44.9% | -18.5% | 1.5% | |
| LTM Mar 2026 | $1.06M | +123.1% | — | 0.1% | |
| LTM Mar 2026 | $0 | +100.0% | -6.7% | 0.0% | |
| Peer median (excluding ADNT) | $97.49M | -5.2% | -5.4% | 2.5% | |
Competitors are the stored peer set for ADNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Sep 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Net Income | 1.11B | (40M) | 295M | 101M | (281M) |
| Depreciation & Amortization | 330M | 350M | 340M | 332M | 325M |
| Deferred Income Tax | 40M | (25M) | (124M) | (1M) | (28M) |
| Stock-Based Compensation | 0 | 29M | 34M | 31M | 0 |
| Change in Working Capital | (227M) | (108M) | 126M | 75M | (45M) |
| Accounts Receivables | 483M | (576M) | 16M | 12M | 31M |
| Inventory | (263M) | (62M) | 126M | 93M | 75M |
| Accounts Payables | (388M) | 558M | (19M) | 90M | (61M) |
| Other Working Capital | (59M) | (28M) | 3M | (120M) | (90M) |
| Other Non-Cash Items | (991M) | 68M | (4M) | 5M | 478M |
| Operating Cash Flow | 260M | 274M | 667M | 543M | 449M |
| Capital Expenditures | (260M) | (227M) | (252M) | (266M) | (245M) |
| Acquisitions (Net) | 604M | 721M | (1M) | (2M) | 88M |
| Purchases of Investments | 0 | (30M) | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 3M | 20M | 24M | 15M | (29M) |
| Investing Cash Flow | 347M | 484M | (229M) | (253M) | (186M) |
| Debt Repayment | (694M) | (1B) | (103M) | (138M) | (20M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | (65M) | (275M) | (125M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (76M) | (272M) | (103M) | (89M) | (122M) |
| Financing Cash Flow | (770M) | (1.27B) | (271M) | (502M) | (267M) |
| Effect of Forex Changes | (8M) | (59M) | (4M) | 47M | 17M |
| Net Change in Cash | (171M) | (574M) | 163M | (165M) | 13M |
| Free Cash Flow | 0 | 47M | 415M | 277M | 204M |
Adient plc
NYSE:ADNT
Intrinsic Alpha fair value
Locked
Current Price
$15.44
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.